Archive

Find out about groundbreaking AI innovations presented by tech giants aimed at improving healthcare delivery and efficiency.

South Africa’s two largest pharmacy chains, Clicks and Dis-Chem, are pushing aggressive expansion plans, reflecting market optimism about their future growth.

Aspen Pharmacare has secured a licensing agreement to enter the GLP-1 agonist market, positioning it for growth in diabetes and obesity treatment solutions.

The rise in TB cases underscores the challenges in global eradication efforts as the disease was the leading cause of infectious disease-related deaths in 2023.

NHI could reshape the nation’s health system, focusing on district health management and prioritising underserved communities.

As demand for budget-friendly health solutions grows, Clicks CEO Bertina Engelbrecht emphasised the group’s commitment to offering more affordable alternatives.

The group’s focus on expansion and efficient cost management has significantly boosted its bottom liner resulting in a 9.6% rise in total revenue to end-August,

Amid controversy, the Independent Development Trust has appointed private contractors for oxygen plants at 55 hospitals, raising red flags about contractor qualifications and budget surges.

Healthcare costs for US obesity patients rise with GLP-1 drugs despite their weight-loss benefits.

Novo Nordisk’s share price dropped 19% amidst growing competition from Eli Lilly in the diabetes and weight-loss drug market.

The Rural Health Advocacy Project is leading a campaign for higher taxes on sugary drinks, alcohol, and tobacco to alleviate the burden on the public health system.